FIJYX vs. FHCCX
Compare and contrast key facts about Fidelity Advisor Biotechnology Fund Class Z (FIJYX) and Fidelity Advisor Health Care Fund Class C (FHCCX).
FIJYX is managed by Fidelity. It was launched on Oct 2, 2018. FHCCX is managed by Fidelity. It was launched on Nov 3, 1997.
Performance
FIJYX vs. FHCCX - Performance Comparison
Loading graphics...
FIJYX vs. FHCCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
FIJYX Fidelity Advisor Biotechnology Fund Class Z | 2.35% | 40.09% | 0.03% | 11.19% | -7.60% | -2.76% | 32.72% | 26.25% | -11.45% |
FHCCX Fidelity Advisor Health Care Fund Class C | -6.24% | -5.49% | 3.20% | 3.02% | -13.72% | 10.43% | 20.15% | 26.96% | -11.29% |
Returns By Period
In the year-to-date period, FIJYX achieves a 2.35% return, which is significantly higher than FHCCX's -6.24% return.
FIJYX
- 1D
- 5.06%
- 1M
- -0.73%
- YTD
- 2.35%
- 6M
- 15.76%
- 1Y
- 55.98%
- 3Y*
- 18.69%
- 5Y*
- 8.12%
- 10Y*
- —
FHCCX
- 1D
- 3.94%
- 1M
- -5.40%
- YTD
- -6.24%
- 6M
- -14.50%
- 1Y
- -9.01%
- 3Y*
- -2.07%
- 5Y*
- -2.42%
- 10Y*
- 5.98%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FIJYX vs. FHCCX - Expense Ratio Comparison
FIJYX has a 0.61% expense ratio, which is lower than FHCCX's 1.72% expense ratio.
Return for Risk
FIJYX vs. FHCCX — Risk / Return Rank
FIJYX
FHCCX
FIJYX vs. FHCCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class Z (FIJYX) and Fidelity Advisor Health Care Fund Class C (FHCCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FIJYX | FHCCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.96 | -0.40 | +2.36 |
Sortino ratioReturn per unit of downside risk | 2.56 | -0.34 | +2.90 |
Omega ratioGain probability vs. loss probability | 1.33 | 0.94 | +0.39 |
Calmar ratioReturn relative to maximum drawdown | 3.20 | -0.43 | +3.62 |
Martin ratioReturn relative to average drawdown | 12.85 | -1.05 | +13.90 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FIJYX | FHCCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.96 | -0.40 | +2.36 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.35 | -0.13 | +0.47 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.31 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.46 | -0.03 |
Correlation
The correlation between FIJYX and FHCCX is 0.82, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FIJYX vs. FHCCX - Dividend Comparison
FIJYX's dividend yield for the trailing twelve months is around 1.41%, while FHCCX has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FIJYX Fidelity Advisor Biotechnology Fund Class Z | 1.41% | 1.44% | 0.00% | 1.55% | 0.00% | 18.90% | 8.13% | 6.49% | 2.35% | 0.00% | 0.00% | 0.00% |
FHCCX Fidelity Advisor Health Care Fund Class C | 0.00% | 0.00% | 17.59% | 0.00% | 0.00% | 8.32% | 6.85% | 0.41% | 6.43% | 0.00% | 0.00% | 7.84% |
Drawdowns
FIJYX vs. FHCCX - Drawdown Comparison
The maximum FIJYX drawdown since its inception was -38.53%, smaller than the maximum FHCCX drawdown of -45.28%. Use the drawdown chart below to compare losses from any high point for FIJYX and FHCCX.
Loading graphics...
Drawdown Indicators
| FIJYX | FHCCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.53% | -45.28% | +6.75% |
Max Drawdown (1Y)Largest decline over 1 year | -13.59% | -27.25% | +13.66% |
Max Drawdown (5Y)Largest decline over 5 years | -36.39% | -29.67% | -6.72% |
Max Drawdown (10Y)Largest decline over 10 years | — | -29.67% | — |
Current DrawdownCurrent decline from peak | -2.49% | -24.39% | +21.90% |
Average DrawdownAverage peak-to-trough decline | -11.76% | -10.12% | -1.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.69% | 11.03% | -7.34% |
Volatility
FIJYX vs. FHCCX - Volatility Comparison
Fidelity Advisor Biotechnology Fund Class Z (FIJYX) has a higher volatility of 9.34% compared to Fidelity Advisor Health Care Fund Class C (FHCCX) at 7.07%. This indicates that FIJYX's price experiences larger fluctuations and is considered to be riskier than FHCCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FIJYX | FHCCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.34% | 7.07% | +2.27% |
Volatility (6M)Calculated over the trailing 6-month period | 17.01% | 22.46% | -5.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.00% | 25.67% | +0.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.43% | 19.41% | +4.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.07% | 19.58% | +5.49% |